Skip to main content

Peer Review reports

From: Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanoma

Original Submission
21 Jun 2011 Submitted Original manuscript
1 Aug 2011 Reviewed Reviewer Report - shubhada chiplunkar
2 Aug 2011 Reviewed Reviewer Report - Claudia Palena
17 Aug 2011 Reviewed Reviewer Report - Tyler Curiel
23 Sep 2011 Author responded Author comments - jason chesney
Resubmission - Version 2
23 Sep 2011 Submitted Manuscript version 2
23 Sep 2011 Author responded Author comments - jason chesney
Resubmission - Version 3
23 Sep 2011 Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
7 Oct 2011 Reviewed Reviewer Report - Claudia Palena
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
13 Dec 2011 Editorially accepted
13 Dec 2011 Article published 10.1186/1471-2407-11-515

You can find further information about peer review here.

Back to article page